Court Backs FDA Rationale For Approving Generic Lovenox
A district court shot down Sanofi-Aventis' arguments against FDA approval of Sandoz's generic Lovenox (enoxaparin)
A district court shot down Sanofi-Aventis' arguments against FDA approval of Sandoz's generic Lovenox (enoxaparin)